Genoray Co., Ltd. (KOSDAQ: 122310)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,700.00
+50.00 (0.88%)
Nov 15, 2024, 9:00 AM KST
-14.16%
Market Cap 76.93B
Revenue (ttm) 108.42B
Net Income (ttm) 10.24B
Shares Out 13.40M
EPS (ttm) 751.40
PE Ratio 7.64
Forward PE n/a
Dividend 160.00 (2.81%)
Ex-Dividend Date n/a
Volume 33,809
Open 5,750.00
Previous Close 5,650.00
Day's Range 5,490.00 - 5,750.00
52-Week Range 5,490.00 - 7,250.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About Genoray

Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It offers C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide. Genoray Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2001
Employees 329
Stock Exchange KOSDAQ
Ticker Symbol 122310
Full Company Profile

Financial Performance

In 2023, Genoray's revenue was 97.90 billion, an increase of 18.51% compared to the previous year's 82.60 billion. Earnings were 12.49 billion, a decrease of -10.17%.

Financial Statements

News

There is no news available yet.